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Abstract  
PURPOSE: Delirium remains a common consequence of critical illness and is known to cause 
negative patient outcomes during an intensive care unit (ICU) stay.  Hence, the purpose of this 
project is to evaluate the outcomes of patients taking psychiatric medications whose medications 
are abruptly discontinued upon admission to an ICU.  Specifically, the outcomes of interest will 
be altered mental status, length of hospital stay, restraint use and mortality. 
METHODS: A correlational analysis using a retrospective chart audit was conducted on 602 
patients admitted to the Neurological/ Neurosurgical ICUs at the University of Kentucky 
Chandler Hospital from January 2015 to December 2015. The proportion of patients who 
experience delirium in the ICU was examined using frequencies and percentages. Chi-square 
analysis was used to assess differences in the proportion of patients who experience delirium and 
the associations between demographics (age, gender, and race), restraint use, admitting 
diagnosis, mortality, and those who were/were not admitted with psychiatric medication. 
Differences in age and length of stay were examined using independent sample t-tests.  
 RESULTS: Those who had psychiatric medications on admission were significantly more likely 
to be female (65.9% vs. 44.7%) and to have a diagnosis of a mood disorder (29.5% vs. 12.1%) 
and anxiety (21.6% vs. 9.3%) disorder. There were no significant differences in length of stay, 
delirium and/or altered mental status, restraint use, and mortality between those with and without 
psychiatric medications on admission. As compared to those without delirium, those with 
delirium were significantly more likely to have a Glasgow coma scale score of 13 or less (68.6% 
vs. 43.9%), to have restraint use (74.5% vs. 37.2%), to be on an antipsychotic (37.3% vs. 11.6%) 
or anxiolytic (70.6% vs. 35.9%) medication, and have longer length of stay (19.9 days vs. 9.6 
days).
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CONCLUSION: There is limited research concerning the treatment of delirium and pre-existing 
psychiatric conditions. Further research is needed to assess if abrupt discontinuation of 
psychiatric medications has any association with delirium.  
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Evaluation Outcomes of Delirium and Abrupt Discontinuation of Psychiatric Medications of the 
Adult Acute Care Patient 
Introduction 
Delirium occurs quite frequently in the intensive care unit (ICU). It is estimated to affect 
up to eighty percent of ICU patients during their acute care hospital stay (American Academy of 
Critical Care Nursing [AACCN], 2011).  This medical condition is associated with short and 
long-term negative patient outcomes, such as increased morbidity, increased six-month 
mortality, increased length of hospitalization, increased odds of disability in activities of daily 
living (ADLs), severe long-term cognitive impairment and higher health care costs (AACCN, 
2011; Breitbart & Alici, 2012; Cerianna et al., 2010; Marino et al., 2015; Ista et al., 2014; Sykes, 
2012). The cost of care for a delirium patient is estimated to be between $4 -16 billion per year 
(AACCN, 2011).  
Delirium is characterized by an alteration in a patient's mental status that causes an 
impairment of attention, altered consciousness, hallucinations, agitation, and sleep disturbance 
that can develop over a short or long period of time (Gilmore & Wolfe, 2013). “Disturbances in 
attention related to delirium occur when a patient has a reduced ability to direct, focus, sustain 
and shift attention and/or reduce awareness of their current environment” (Diagnostic and 
Statistical Manual of Mental Disorders 5th ed. [DSM-5], 2013, p. 596; American Psychiatric 
Association, 2013).  Cognitive disturbances may fluctuate with severity and can affect a 
memory, disorientation, language, visuospatial ability, and perception (DSM-5).  
The pathophysiology of delirium is unknown; theories include the condition may be a 
direct physiological consequence of a side-effect from a medication, substance intoxication or 
withdrawal of medication (drug abuse or due to a lack thereof a medication), exposure to toxins 
and/or multiple other etiologies (DSM-5
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, 2013). Many researchers have theorized and studied delirium as a secondary condition 
due to lack of sleep and/or interruption of a patient’s daily routine (termed ICU psychosis) (Ely 
et al., 2004 & Ceriana et al., 2010). Other researchers have studied the side effects of 
medications, such as benzodiazepines, analgesics, and anesthetics and their association with 
delirium (Ely et al., 2004 & Ceriana et al., 2010).  Common medical conditions that are 
associated with a delirium diagnosis include sepsis, hypoxia, hypothermia, hyperglycemia, 
hepatic and renal insufficiencies, thyroid dysfunction, adverse effects to drug intoxications, 
chemical withdrawal, and anticholinergic agents (Arend & Christensen, 2009; Ely et al., 2004; 
Ceriana et al., 2010).       
Other theories of the pathophysiology of delirium suggest that it is caused by a 
combination of predisposing factors and precipitating factors (Arend & Christensen, 2009; 
Ceriana et al., 2010; Hosie et al., 2013; McPherson, 2013). Predisposing factors are present at the 
time of hospital admission and include: advanced age (>70), hearing loss, dementia, transfer 
from a nursing home, alcohol abuse, smoker, illegal drug abuse, visual impairment, elevated 
urea-creatinine ratio, history of stroke, epilepsy, congestive heart failure and/or depression 
(Arend et al., 2009; Ceriana et al., 2010; Hosie et al., 2013; McPherson, 2013). Precipitating 
factors for delirium consist of acute illness, pharmacological agents, environmental factors 
(noise, lights, frequent interruptions, sensory overload, lack of windows), emotional issues 
(anxiety, fear, pre-existing psychological factors, coping skills), and medical equipment 
(restraints, presence of chest and/or endotracheal tubes, bladder catheters, invasive monitoring 
lines) (Arend et al., 2009; Ceriana et al., 2010; McPherson, 2013).   Pharmacological agents that 
are associated with delirium include anesthetics, analgesics, antibiotics, anticholinergics, 
sedatives, steroids, psychopharmacological agents, and abrupt discontinuation of medications 
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(Arend et al., 2009; Cerianna et al., 2010 & McPherson et al., 2013). The concerns in relation to 
pharmacological agents are their effects on the brain; studies have shown that these agents have 
the potential to interfere with brain function and can lead to confusion, altered level of 
consciousness, and disorientation (Arend et al., 2009; Cerianna et al., 2010; McPherson et al., 
2013). 
Delirium is not commonly the cause of an acute care hospital stay and often goes 
unnoticed by healthcare workers until it has already developed (Ceriana et al., 2010). Generally, 
patients are admitted to the ICU with multi-organ failure, sepsis, stroke or trauma conditions; as 
a result, delirium can be easily overlooked. Once a patient is admitted to an acute care hospital, it 
is common practice to abruptly stop all currently prescribed medications until the patient has 
stabilized and a pharmacist can review medications. However, the abrupt discontinuation of 
certain medications, especially medications for long-term use, can cause withdrawal effects that 
could be observed as delirium in a patient (Arend et al., 2009).  Thus, the abrupt withdrawal of 
medications upon entering the acute care hospital is a worthy concept to examine in relation to 
delirium cause theory. 
Moreover, in 2008, the American Psychological Association (APA) reported an estimated 
one in ten persons in the U.S. is prescribed psychotropic medications. The APA also indicated 
that the prescribing of psychotropic medications increased between 2002 and 2006, with 
antidepressants prescriptions increasing by 12%, anxiety medications by 16% and antipsychotics 
by 35% (APA, 2008). The abrupt withdrawal of psychopharmacological medications upon 
hospital admission is not recommended (Burns et al., 2002). The sudden withdrawal of these 
medications can cause a patient to experience exacerbations or reemergence of psychotic 
symptoms, withdrawal symptoms (restlessness, insomnia, anxiety, confusion, nausea/vomiting, 
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cold sweats, muscular aches and pains, diaphoresis), and neuroleptic malignant syndrome, all of 
which can be misinterpreted as ICU delirium (Burns et al., 2002). 
Problem Statement 
Delirium research to date has focused on causes, risk factors, negative patient outcomes, 
economic consequences, assessment tools and their reliability and validity, medication treatment, 
and prevention protocols. However, there is a gap in the literature with regard to the factors 
associated with delirium and altered mental status among psychiatric patients in the ICU.  
Examining factors associated with delirium and altered mental status among psychiatric patients 
is critical to understand ways to mitigate ICU delirium. The abrupt discontinuation of home 
psychotropic medications may exacerbate a patient's psychotic symptoms (National Institutes of 
Mental Health, 2010). Hence, studying patient outcomes associated with the discontinuation of 
medications during an acute care hospitalization can provide important evidence for the 
development of patient care procedures and policies to minimize ICU-associated delirium and 
altered mental status.  
Objective/Aims 
The purpose of this project was to examine factors associated with delirium and altered 
mental status among patients in the ICU. Specifically, the goal was to assess the associations 
between having psychiatric medications on admission and delirium, altered mental status, length 
of hospital stay, restraint use, and mortality. 
The specific aim was: 
AIM 1: To determine the differences in demographics, length of stay, restraint use, and mortality 
between those with and without delirium.  
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AIM 2: To examine differences in demographics, length of stay, delirium, restraint use, and 
mortality between patients with and without psychiatric medications.  
Methods 
Setting 
The analysis was conducted in the neurological and neurosurgical intensive care units 
(ICUs) of the University of Kentucky Chandler Hospital, a Level 1 Trauma medical center in 
Lexington. These two units (24 beds) have a total of 220 health care providers who serve 
approximately 235 patients monthly. 
Study Design  
 A retrospective chart audit was conducted on patients admitted to the neurological and 
neurosurgical ICUs. Data from 602 patients who were admitted to the ICUs from January 2015 
to December 2015 were extracted from electronic medical records (EMR).   
Sample  
  Inclusion criteria for patients were: a) 18 years of age or older and b) ICU length of stay 
> 72 hours. Exclusion criteria were patients diagnosed with: a) Moderate to severe dementia, b) 
structural brain damage, c) history of Parkinson disease, d) hepatic encephalopathy, and e) 
sodium level >150. In addition, patients receiving benzodiazepines for alcohol withdrawal were 
further excluded. Patients diagnosed with these conditions were excluded because these 
diseases/disorders share similar symptoms with delirium. Patients were also excluded if their 
medical records had insufficient data. A medical record with insufficient data was defined as a 
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record that was missing information on neurological assessments, and/or pharmacy medication 
reconciliation verification documents.  
Procedures 
Retrospective patient data were obtained from electronic medical records from January to 
December 2015. The electronic medical records are secured on the system at UK HealthCare. 
UK Information Technology queried the database for patients that met the specific inclusion 
criteria. Demographic variables along with main outcome variables were extracted for the study. 
De-identified retrieved data were recorded on a spreadsheet for data analysis. Because this study 
was based on a retrospective analysis, a waiver of documentation of patient consent was obtained 
from the University of Kentucky Institutional Review Board prior to EMR review. 
Measures:  
The following measures were extracted from the electronic medical records (see Table 1):  
1. Demographic data: Demographic data included sex (male vs. female), age (in years), and 
admitting diagnosis (reason for acute care admission), and race (ethnicity: African 
American/Black, Caucasian/white, Hispanic, Black Hispanic, White Hispanic, and/or other).  
2. Medication reconciliation document: The medication reconciliation document was used to 
determine which patients were prescribed with psychiatric medications prior to admission 
and which medications were prescribed to patients during hospital stay. 
3. Delirium: Diagnostic codes related to” delirium,” “delirium due to alcohol withdrawal or 
drug withdrawal,” or “disorientation,”’ or “altered mental status,” or “restlessness and 
agitation” were obtained from the medical record. These codes are related to the Confusion 
Assessment Method for the ICU (CAM-ICU) score (i.e., a code for delirium). These 
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diagnostic codes were recoded as ‘0’ for none, or ‘1’ for ‘delirium/disorientation/altered 
mental status’  
4. Neurological assessment: Neurological assessments involved determining if the patient had 
a change in level of consciousness, Glasgow Coma Scale, and/or documentation of the 
patient being acutely confused. The neurological assessments were used to further determine 
if a patient met the criteria for a positive CAM-ICU score.  
5. Length of stay:  Total number of days patient admitted into the University of Kentucky 
Chandler Hospital  
6. Restraint use: Patient history of restraint use during the acute care hospital stay.  
7. Mortality rate: Patients who expired during the ICU stay. 
Data Analysis    
For aim 1, the proportion of patients who experience delirium in the ICU was described 
using frequencies and percentages. Demographic differences in the proportion of patients who 
experience delirium were also examined by using chi-square analysis to assess differences by 
sex, admitting diagnosis and race; whereas differences in age were analyzed using independent 
sample t-tests.  In addition, the differences in the proportion of patients that exhibit delirium 
between those who and who were not admitted with psychiatric medications were examined 
using chi-square analyses.  
For aim 2, independent sample t-tests were used to examine differences in length of stay between 
those who were admitted with psychiatric medications and those who were not. Chi-square 
analyses were used to examine differences between these two groups with regard to restraint use 
and mortality.  
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Results 
Sample Characteristics 
The sample (N = 602) was primarily male (52.2%), white (91.7%), and on average 60.0 
(SD = 17.3) years of age. The majority of the sample had a primary medical diagnosis of cerebral 
infarction and hemorrhage (52.5%), followed by arterial embolism/aortic aneurysm (21.9%), or 
other neurosurgery diagnosis (13.3%).  The primary psychiatric diagnosis was mood disorders 
(14.6%), followed by substance use disorder (12.3%). Nearly half of the sample had a Glasgow 
coma scale score of 13 or less (46.0%), 40% experienced restraint use during hospitalization, and 
5.1% expired. The average length of stay was 10.4 days (SD=13.8; see Table 2). 
Differences in demographic, length of stay, restraint use, and mortality between those with 
and without Delirium 
Table 2 presents the differences in demographics, length of stay, restraint use, mortality, 
and psychiatric medication use between those with and without delirium. As compared to those 
without delirium, patients with delirium were significantly more likely to have a mood disorder 
(21.6% vs. 14.0%), cognitive/psychotic/sexual dysfunction (11.8% vs. 5.4%), and substance use 
disorder (29.4% vs. 10.7%). In addition, those with delirium were significantly more likely to 
have a Glasgow coma scale score of 13 or less (68.6% vs. 43.9%), to have restraint use (74.5% 
vs. 37.2%), to be on an antipsychotic (37.3% vs. 11.6%) or anxiolytic (70.6% vs. 35.9%) 
medication, and had a significantly longer length of stay (19.9 days vs 9.6 days). There were no 
other significant differences between those with and without delirium (see Table 2).    
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Demographic, Length of Stay, delirium, Restraint Use, and Mortality differences between 
those with and without Psychiatric Medications on Admission  
Table 3 presents differences in demographics, length of stay, delirium, restraint use, and 
mortality between those with and without psychiatric medications on admission. As compared to 
those without psychiatric medications on admission, those who had psychiatric medications on 
admission were significantly more likely to be female (65.9% vs. 44.7%) and to have a primary 
psychiatric diagnosis of a mood (29.5% vs. 12.1%), anxiety (21.6% vs. 9.3%), or 
cognitive/psychotic/sexual dysfunction (10.2% vs. 5.3%). However, there were no significant 
differences in length of stay, delirium and/or altered mental status, restraint use, and mortality 
between those with and without psychiatric medications on admission (see Table 3).   
Discussion 
  This study examined factors that are associated with delirium and altered mental status in 
the ICU, as well as the impact of discontinuation of psychiatric medications upon admission on 
patient outcomes. To my knowledge, this is the first study to examine the relationship between 
discontinuation of psychiatric medications and delirium and how such interruption affects the 
patients' length of stay, restraint use, and mortality. This study established that there are no 
significant differences in the occurrence of delirium between patients admitted to the ICU with 
psychiatric medications and those admitted without psychiatric medications (8.0% versus 8.6%; 
χ2 = 0.04 [df=1], p =.850). In other words, abrupt discontinuation of psychiatric medications 
upon admission may not be a factor for delirium development for ICU patients. However, there 
were associations between anxiolytic and antipsychotic medications and delirium. These findings 
EVALUATION OF DELIRIUM                                                                                          
  
 
12 
 
have several implications for nursing research and practice, and indicate a need to develop 
technology for the documentation of accurate assessments for delirium.  
Patient Characteristics 
The sample for this study was primarily male (52.5%); however, patients that were 
admitted with psychiatric medications were significantly more likely to be female (65.9% vs. 
44.7%). This finding is similar to a study by Gopalan et al. (2016), who found that the majority 
of patients with a psychiatric disorder were female. However, in this study the incidence of 
delirium by gender was not significant, χ2 (1, N = 602) =0.49, p= 0.482.  No previous studies 
have compared gender differences in psychiatric diagnosis and delirium.  
 The average length of stay of our sample was 10.4 days. Consistent with previous studies 
(Cavallazzi et al., 2012;  Brietbart & Alici, 2012; Cerianna et al., 2010), patients who 
experienced delirium were significantly more likely to have a longer length of stay as compared 
to patients who did not experience delirium (19.9 days vs. 9.6 days). However, patients who 
were admitted with psychiatric medications in the current study showed no significant difference 
in length of stay compared to those patients without psychiatric medications. The lack of 
difference in delirium between those with and without psychiatric medications on admission may 
suggest that psychiatric medication discontinuation is not a factor for delirium onset. Even so, 
more studies should be conducted to replicate this result to establish a lack of association 
between psychiatric medication discontinuation and delirium development. 
Current non-medication management of delirium includes physical restraints on the 
patients to prevent device removal and self-harm in agitated patients. However, by limiting 
movements, physical restraints have been shown to have an adverse physical and psychological 
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effect, including delirium (Cerianne et al., 2010; McPherson et al., 2013; Brieibart & Alici, 
2012). In this study, restraints were used for 40% of the sample, and patients who experienced 
delirium were significantly more likely to have restraints as compared to those who did not 
experience delirium (74.5% vs. 37.2%).  Cerianne et al. (2010) reported that the use of physical 
restraints was a predisposing risk factor for the development of delirium when patients were 
transitioned from an ICU to a step-down unit. McPherson et al. (2013) also found that physical 
and chemical (medications such as a benzodiazepine) restraints are predisposing risk factors for 
delirium. Unfortunately, current practices for delirium treatment include physical restraint of the 
altered mental status patient (AACCN, 2011; Breitbart & Alici, 2012).  Hence, restraint use 
should be a last resort for delirium treatment; prompt recognition of symptoms and early 
mobilization of patients may decrease the number of days of delirium (AACCN, 2011; Breitbart 
& Alici, 2012).  
Psychiatric Diagnosis  
This study further found an association between delirium in the ICU and mood disorder 
prevalence, and this is consistent with recent research. For example, Gopalan et al. (2016) cited 
in their study that included 384 subjects that 10.9% of that population had a major depressive 
disorder and 33.5% of that population had a diagnosis of either anxiety or depressive disorder. 
This is similar to the findings of our current study, as the primary psychiatric diagnosis for the 
patients was mood disorder (14.6%); patients that were admitted with psychiatric medications 
had a diagnosis of mood disorder (29.5%) and patients that experienced delirium was 
significantly more likely to have a mood disorder (21.9%).  Ghoneim and O'Hara (2016) 
conducted a literature review and identified depression as an independent risk factor for 
postoperative delirium. One study found a 13.7% incidence of depression among patients on the 
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first day of admission to the ICU (Rincon et al., 2001). Another study demonstrated a 32% 
incidence of depression or PTSD in patients who were admitted to the ICU to receive abdominal 
aortic surgery (Liberzon et al., 2006). Ghoneim and O'Hara (2016) concluded that patients with 
preoperative depressive symptoms are more likely to develop postoperative delirium for a longer 
duration and experience an incomplete recovery to independent functioning post-surgery.  
Followed by mood disorders, substance use disorders (12.3%) were the primary 
psychiatric diagnosis for the patient population of this study. Patients with a diagnosis of a 
substance abuse disorder are more likely to experience delirium (29.4% vs. 10.7%). However, at 
admission to the ICU, these patients were not admitted with psychiatric medications. Prior 
studies have concluded that substance abuse withdrawal is a risk factor for delirium (Arend et al., 
2009; Ceriana et al., 2010; Hosie et al., 2013; McPherson et al., 2013).  Patients in the ICU with 
an alcohol abuse disorder are at increased risk for alcohol withdrawal syndrome (AWS) (Sutten 
& Jutel, 2016). Alcohol withdrawal syndrome and alcohol abuse disorder can prolong the 
patient’s length of stay, increase the patient’s risk for infectious complications, increase their risk 
for delirium, and predispose the patient for mechanical ventilation assistance (Sutten & Jutel, 
2016).  
Psychiatric Medications 
Anxiolytic and antipsychotic medications were associated with delirium for this study. 
Patients with a history of anxiolytic (70.6% vs. 35.9%) and antipsychotic (37.3% vs. 11.6%) 
medications use were significantly more likely to develop delirium. Medications that have a 
precipitating risk factor for delirium include anesthetics, analgesics, antibiotics, anticholinergics, 
sedatives, steroids and psychopharmacological agents (Arend et al., 2009; Cerianna et al., 2010; 
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McPherson et al., 2013). Benzodiazepines can promote delirium (Cavallazzi et al., 2012). Also, 
lorazepam independently increases the risk for the development of delirium, whereas propofol 
and opiates do not (Cavallazzi et al., 2012).  Benzodiazepines should be avoided in critically ill 
patients in the ICU, because they are a high-risk factor for delirium, and studies have shown that 
limiting their use may decrease the overall incidence of delirium in the ICU (Cavallazzi et al., 
2012; Arend et al., 2009; Cerianna et al., 2010; McPherson et al., 2013). Benzodiazepines are not 
recommended for treating delirium; however, patients with a benzodiazepine dependence and/or 
long-term use should not be abruptly discontinued from this medication because it can cause 
withdrawal and/or delirium (Cavallazzi et al., 2012). Unfortunately, for patients with AWS, a 
slow taper off benzodiazepines is the recommended treatment therapy to prevent withdrawal 
associated delirium (Cavallazzi et al., 2012).   
Abrupt withdrawal of antipsychotic medications is not recommended, and the standard of 
care is to slowly taper off these medications (Burns et al., 2002).  The sudden withdrawal of 
these medications can cause a patient to experience exacerbation or reemergence of psychotic 
symptoms, withdrawal symptoms (restlessness, insomnia, anxiety, confusion, nausea/vomiting, 
cold sweats, muscular aches and pains, diaphoresis), and neuroleptic malignant syndrome, all of 
which could be mistaken by the medical personnel as ICU delirium (Burns et al., 2002). In 
contrast, the use of antipsychotic medications is a potential treatment for delirium (Breitbart & 
Alici, 2012; Gilchrist et al., 2012).  
Breitbart & Alici (2012) conducted a systemic review of evidence-based delirium 
treatment of cancer patients. They found that antipsychotic medications were effective in 
improving or resolving symptoms of delirium in patients. Low-dose haloperidol was the most 
suitable medication, and atypical antipsychotics should be considered as effective alternatives to 
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Haldol (Breitbart & Alici, 2012). However, the use of pharmacological interventions for the 
prevention of delirium has not been supported by evidence, because prevention studies are so 
sparse (Breitbart & Alici, 2012).  In contrast, Gilchrist et al. (2012) conducted a comprehensive 
review and found that atypical antipsychotics were just as effective as Haldol for ICU delirium 
for short-term treatment therapy. However, they concluded that further studies are needed to 
further evaluate this drug therapy.   
Recent research on delirium and antipsychotic medications focus more on the use of 
antipsychotic medications as a prophylactic delirium treatment. Gilmore and Wolfe (2012) 
conducted a meta-analysis study of existing trials that compared delirium incidence among 
patients given prophylactic antipsychotic medications versus post-surgical patients there were 
given placebos. They concluded that prophylactic antipsychotic medications given to surgical 
patients decreased the incidence of delirium (Gilmore & Wolfe, 2012). However, they also found 
that prophylactic antipsychotic medications did not reduce the length of stay, or the duration or 
severity of delirium (Gilmore & Wolfe, 2012). Callvallazzi et al. (2012) found when Haldol (0.5 
mg followed by an infusion of 0.1mg/hr over 12 hours) was used for prevention of delirium in 
the ICU, patients had a significant decrease in the incidence of delirium within the first seven 
days after surgery (15.3% vs. 23.2%; p=0.031), and a decreased length of ICU stay (21.3 hours 
vs. 23 hours; p=0.024).  
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Limitations 
A few important limitations should be considered in interpreting the findings of this 
study. First, an original aim of this study was to determine the difference in the proportion of 
patients that develop ICU delirium between patients with and without psychiatric medication on 
admission using the CAM-ICU assessment tool (AACCN, 2011). However, between the two 
units from which patient data were obtained, only 78 patients that year were assessed for ICU 
delirium using the evidence-based CAM-ICU scale. Consequently, none of these 78 patients met 
the study criteria. So, to determine if patients had experienced delirium in the ICU, the patients 
who were assessed as having a GCS <13 and were coded with the diagnostic billing codes of 
disorientation, altered mental status, restless and agitated, unspecified psychosis and Glasgow 
coma scale 9-12, were used as a proxy for delirium. The diagnostic billing code for 
disorientation, altered mental status, restless and agitation, unspecified psychosis and a Glasgow 
coma scale 9-12 would equal a positive CAM-ICU if scored correctly on the scale (Gilmore & 
Wolfe, 2013). Sacynski et al. (2014) were also successfully able to identify delirium patients in 
the hospital setting by using a chart-based delirium instrument tool to identify delirium. Their 
tool used terms such as change of mental status, evidence of agitation and confusion. 
Second, these data show that the majority of the patients in this study had a neurological 
diagnosis as their primary diagnosis (52.5%), which is consistent with the study setting, two 
specialty neurological ICUs (Sacynski et al., 2014). Alterations in consciousness might be severe 
enough to preclude assessment of delirium and altered mental status. It is unknown if setting the 
study in a different ICU, such as a medical or trauma unit, would have yielded different results.   
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Finally, time constraints were a limitation factor for this study. Due to deadline 
constraints, I was unable to look at the length of time it took for psychiatric medications to be 
restarted, to investigate individual electronic medical records for provider notes for more 
descriptive assessments for delirium and altered mental status, and further investigate why 
patients were not being assessed for delirium every shift.  Regardless of these limitations, the 
strengths of this study provide direction for doctoral nursing practice and research to improve the 
outcome of ICU patients who have complex medical and psychiatric needs.  
Implications for Future Doctoral Nursing Practice and Research 
Delirium Assessment   
 One recommendation for future research is to investigate why ICU nurses may not be 
using the delirium assessment tool, CAM-ICU, daily.  This study found that in 2015, both ICU 
units only assessed 78 patients using the CAM-ICU assessment tool in their EMR.  Providing 
delirium screening to critically ill patients with a validated assessment tool could give providers 
the potential causative agent for delirium and prompt discussion of early treatment or prevention 
in daily multidisciplinary rounds.  
Providing continuous monitoring for delirium by the bedside nurse is an essential need to 
successfully assess and treat delirium. Delirium in the ICU goes undetected by healthcare 
professionals 65% of the time (AACN, 2011). The AACN recommends that ICU critical care 
nurses use a standardized and validated assessment tool for delirium screening for all patients 
(2011). Assessment for delirium for the ICU patient is to be performed twice a day with the use 
of validated assessment tools such as the CAM-ICU or Intensive Care Delirium Screening 
Checklist (ICDSC) (Neto et al., 2012 &AACN, 2011).  
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Current research on delirium assessment suggests that in addition to the CAM-ICU 
and/or ICDSC, sedation should also be assessed at the time of delirium screening. Neto et al. 
(2012) suggest that before assessing the patient for delirium using the CAM-ICU, the patient's 
level of consciousness should be evaluated first using the validated tool, the Richmond Agitation 
Sedation Scale. Patients assessed using the Richmond Agitation Sedation Scale with a score >-3 
are deemed to be appropriate for an assessment using the CAM-ICU for delirium (Neto et al., 
2012).  The researchers also recommend that delirium evaluation should be performed by a 
neurologist, neurophysiologist, psychiatrist, psychiatric nurse practitioner, and/or clinical 
geriatrician, as this should be the "gold standard" for a diagnosis of delirium (Neto et al., 2012). 
Medication Reconciliation  
  The second recommendation for further evidence-based nursing practice is to 
investigate the discontinuation of psychiatric medications and how long it takes to restart such 
medications. The restarting of medications was not investigated during this study because of time 
constraints. Also, current research is focused on the use of antipsychotic medications as a 
treatment for delirium. However, patients in this study were significantly more likely to develop 
delirium when admitted into the ICU on antipsychotic medication.  Further investigation is 
needed into why there is a lack of medication reconciliation for psychiatric medications, as well 
as what is the average length of time it takes to restart psychiatric medications for ICU patients.   
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Implications Using DNP Essentials  
To further investigate ICU delirium assessment and medication reconciliation into 
practice and research on the Neurological ICU units, a Doctoral Nursing Practice (DNP) 
graduate will be able to apply the following DNP Essentials: Essential III, Clinical Scholarship; 
Essential IV, Information Technology and Patient Care Technology for the Improvement and 
Transformation of Healthcare; and Essential VIII, Advanced Nursing Practice.  The AACN 
(2006) states that the DNP graduate is capable of engaging in advanced nursing practice and 
providing leadership for evidence-based practice. DNP Essential III states that a “graduate is 
competent in knowledge application, such as the translation of research into practice, 
improvement of the reliability of health care practice and outcomes, and the evaluation of 
practice and participation in collaborative research” (AACN, p. 12,2006).  An investigation of 
why delirium assessments are not being performed could consist of the DNP graduate 
conducting chart audits of the bedside nurses to assess again if they are being performed (as this 
study was a retrospective chart review of the year 2015). The DNP graduate could educate the 
bedside nurses about delirium, how to assess the patient, and the charting assessment tool, and 
then reassess compliance levels of delirium assessments after re-education of bedside nurses.  
DNP Essential IV states that a DNP graduate is distinguished in his or her ability to use 
information systems/technology, from supporting and improving patient care to applying new 
knowledge, provide proficient leadership and assessing the efficacy of patient care technology 
(AACN, 2006).  The DNP graduate is prepared to not only evaluate programs but also to design, 
select, and use programs that assess and monitor outcomes of care, care systems, and quality 
improvement of health care information systems (AACN, 2006). Implications for future practice 
using Essential IV would involve the DNP graduate assessing the EMR delirium assessment and 
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investigating why bedside nurses are failing to comply. The investigation would include an 
involvement with Information Technology (IT), again based on why the delirium assessments 
are not being charted. An IT investigation could include the location of the delirium assessment 
tool within the EMR.  In addition, for medication reconciliation, IT could be consulted to help 
design and implement a standardized medication reconciliation note in the EMR for the 
medications present at admission. Currently, this is not available in the EMR used in this study 
setting and is only included in a provider note; this is why the medication restart information was 
difficult to find and was not included in this study.  
 According to the AACN (2006), "all DNP graduates are expected to demonstrate refined 
assessment skills and base practice on the application of biophysical, psychosocial, behavioral, 
sociopolitical, cultural, economic, and nursing science as appropriate in their area of 
specialization” (p. 16). This refers to DNP Essential VIII, Advanced Nursing Practice. This 
Essential ensures that the DNP graduate is prepared to design, implement, and evaluate 
therapeutic interventions based not only on nursing science, but other sciences as well (AACN, 
2006). In addition, the DNP graduate is prepared to demonstrate advanced levels of clinical 
judgment, systems thinking and accountability when evaluating evidence-based care to improve 
patient outcomes (AACN, 2006). The use of DNP Essential VIII for this study is that the 
graduate can not only study the problem of delirium assessment but can further assess what is 
required to ensure that patients are being evaluated, and implementing clinical judgment to 
improve outcomes for patients who experience delirium. The DNP graduate knows that it is 
essential to not only treat but prevent delirium, so that the patient does not experience increased 
length of stay, restraints, or falls during their hospitalization. To prevent these negative 
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outcomes, the DNP graduate could implement programs that resulted from this research into 
everyday evidence-based practice.  
 Conclusions 
Delirium is a serious condition that requires the immediate attention of hospital 
personnel. This clinical problem requires quick and accurate clinical assessment, as well as 
immediate treatment to reduce the incidence and negative patient outcomes. Delirium is 
considered to be a preventable health condition, and with immediate recognition of risk factors, 
CAM-ICU assessments, and proper treatment management, the prevalence in the acute care 
hospital should decrease (AACCN, 2013; APA, 2004; Neto et al., 2012; Carbone et al., 2015). 
However, there is limited research concerning the treatment of delirium and psychiatric 
conditions. In conclusion, further research is needed to assess if abrupt discontinuation of 
psychiatric medications increases patients for risk for delirium. 
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Table 1. Measures  
 
Variable name   Measures  Data source  Level of 
measure  
Statistical 
analysis  
Aim 1  
Medication 
reconciliation 
document  
Name of home 
psychiatric 
medication 
prescribed to patient  
And yes/no if 
psychiatric 
medication present 
upon admission 
EMR Nominal  Frequency (%) 
 
Chi-square 
analysis  
Delirium  Based on diagnostic 
code (yes/no) 
EMR  Nominal Frequency (%)  
Chi-square 
analysis  
Neurological 
assessment 
Glasgow Coma 
Scale  
EMR Interval  Mean (SD)  
Chi-square 
analysis  
Aim 2  
Length of hospital 
stay  
Number of days  EMR  Interval  Mean (SD)  
Independent  T-
Test 
Restraint used  Yes/no  EMR Nominal Frequency  
Chi-Square 
analysis  
DEMOGRAPHICS  
Age  Age of participant in 
years 
EMR Nominal  Mean (SD) 
Sex  Sex (male, female, 
other) 
EMR Nominal  Frequency  
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Race  Ethnicity (African 
American/Black, 
Caucasian/white, 
Hispanic, Black 
Hispanic, White 
Hispanic)  
EMR Nominal  Frequency  
Admitting 
diagnosis  
Reason for acute 
care admission 
EMR Nominal  Frequency  
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Table 2. Demographic, Length of Stay, Restraint Use, Mortality, and Psychiatric 
Medications Use differences between those with and without Delirium 
 Total 
(N=602) 
Patients with 
Delirium 
(n=51) 
Patients 
without 
Delirium 
(n=551) 
Differences 
Chi square (df), p-
value 
 N % n % n %  
Sex        .49 (1), p =.482 
Male 314 52.2 29 56.9 285 51.7  
Female 288 47.8 22 43.1 266 48.3  
Ethnicity       .16 (1), p=.685 
White 
 
552 91.7 46 90.2 506 91.8  
Non-White 
 
50 8.3 5 9.8 45 8.2  
Psychiatric Diagnosis        27.52 (4), p<.0001 
None 337 56.0 13 25.5 324 58.8  
Mood 88 14.6 11 21.6 77 14.0  
Anxiety 67 11.1 6 11.8 61 11.1  
Cognitive & Psychotic & Sexual 
Dysfunction 
36 6.0 6 11.8 30 5.4  
Substance Use 74 12.3 15 29.4 59 10.7  
Primary Diagnosis        5.92 (5), p=.315 
Cerebral Infarction and 
Hemorrhage 
316 52.5 26 51.0 290 52.6  
Traumatic Brain 40 6.6 5 9.8 35 6.4  
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Injury/Falls/MVA 
Arterial embolism/stent/Aortic 
Aneurysm 
132 21.9 9 17.6 123 22.3  
Spinal Cord Injury 18 3.0 4 7.8 14 2.5  
Malignant and Benign 
Neoplasm 
16 2.7 1 2.0 15 2.7  
Other Neurosurgery or 
Diagnosis (Epilepsy, congenital 
issues, endocardial issues, 
Encephalopathy,etc.) 
80 13.3 6 11.8 74 13.4  
Glasgow Coma Scale        11.47 (1), p=.001 
Greater than 13 325 54.0 16 31.4 309 56.1  
13 or less 277 46.0 35 68.6 242 43.9  
Restraint Use        27.0 (1), p<.0001 
No 359 59.6 13 25,5 346 62.8  
Yes 243 40.4 38 74.5 205 37.2  
Mortality       1.16 (1), p=.281 
No 571 94.9 50 98.0 521 94.6  
Yes 31 5.1 1 2.0 30 5.4  
Antipsychotic 83 13.8 19 37.3 64 11.6 25.82 (1), p<.0001 
Anxiolytics 234 38.9 36 70.6 198 35.9 23.59 (1), p<.0001 
Antidepressants 156 25.9 13 25.5 143 26.0 .01 (1), p=.942 
Anticonvulsants 19 3.2 2 3.9 17 3.1 .11 (1), p=.744 
 m sd m sd m sd Differences 
t-test (df), p-value 
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Age (years) 60.0 17.3 61.5 19.2 59.9 17.2 .66 (600), p=.509 
Length of Stay (days) 10.4 13.8 19.9 25.4 9.6 11.9 2.83 (50.97), p=.007 
*differences were calculated using chi square analyses for categorical data and independent 
sample t-test (with Levine’s test for equality of variance) for continuous variables. 
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Table 3. Differences in demographics, length of stay, restraints used, and mortality between 
patients with and without psychiatric medications on admission who experience delirium 
and/or altered mental status  
 
 Total 
(N=602) 
Patients with 
Psych Meds 
(n=88) 
Patients 
without 
Psych Meds 
(n=514) 
Differences 
Chi square (df), p-
value 
 N % n % n %  
Sex        13.5 (1), p <.0001 
Male 314 52.2 30 34.1 284 55.3  
Female 288 47.8 58 65.9 230 44.7  
Ethnicity       .01 (1), p=.897 
White 
 
552 91.7 81 92.0 471 91.6  
Non-White 
 
50 8.3 7 8.0 43 8.4  
Psychiatric Diagnosis        43.3 (4), p<.0001 
None 337 56.0 25 28.4 312 60.7  
Mood 88 14.6 26 29.5 62 12.1  
Anxiety 67 11.1 19 21.6 48 9.3  
Cognitive & Psychotic & Sexual 
Dysfunction 
36 6.0 9 10.2 27 5.3  
Substance Use 74 12.3 9 10.2 65 12.6  
Primary Diagnosis        3.8 (5), p=.574 
Cerebral Infarction and 316 52.5 47 53.4 269 52.3  
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Hemorrhage 
Traumatic Brain 
Injury/Falls/MVA 
40 6.6 3 3.4 37 7.2  
Arterial embolism/stent/Aortic 
Aneurysm 
132 21.9 18 20.5 114 22.2  
Spinal Cord Injury 18 3.0 2 2.3 16 3.1  
Malignant and Benign 
Neoplasm 
16 2.7 2 2.3 14 2.7  
Other Neurosurgery or 
Diagnosis (Epilepsy, congenital 
issues, endocardial issues, 
Encephalopathy,etc.) 
80 13.3 16 18.2 64 12.5  
Delirium       .04 (1), p=.850 
No 551 91.5 81 92.0 470 91.4  
Yes 51 8.5 7 8.0 44 8.6  
Glasgow Coma Scale        3.0 (1), p=.083 
Greater than 13 325 54.0 55 62.5 270 52.5  
13 or less 277 46.0 33 37.5 244 47.5  
Restraint Use        .01 (1), p=.910 
No 359 59.6 52 59.1 307 59.7  
Yes 243 40.4 36 40.9 207 40.3  
Mortality       1.74 (1), p=.186 
No 571 94.9 86 97.7 485 94.4  
Yes 31 5.1 2 2.3 29 5.6  
 m sd m sd m sd Differences 
t-test (df), p-value 
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Age (years) 60.0 17.3 60.8 16.9 59.9 17.4 .45 (600), p=.652 
Length of Stay (days) 10.4 13.8 8.7 8.0 10.7 14.6 1.26 (204.2), p=.060 
*differences were calculated using chi square analyses for categorical data and independent 
sample t-test (with Levine’s test for equality of variance) for continuous variables. 
 
